Chernett Jorey 4

What Happened
Chernett Jorey, a reported 10% owner of Oncology Institute, Inc. (TOI), purchased 50,000 common shares on 2026-03-26. The filing reports a weighted-average purchase price of $3.15 per share, for a total transaction value of approximately $157,500. This was a purchase (code P), which is generally viewed as a bullish signal because the insider added shares rather than selling.

Key Details

• Transaction date: 2026-03-26 (Form 4 filed 2026-03-27 — appears timely).
• Transaction type/code: Purchase (P) — open market or private purchase.
• Shares purchased: 50,000 at a weighted-average price of $3.15; total ≈ $157,500.
• Price range (footnote): Purchases occurred in multiple trades at prices between $3.11 and $3.19; $3.15 is the rounded weighted average. The filer offers to provide a breakdown of quantities at each price on request (footnote F1).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Reported the day after the transaction — no late-filing indication in the excerpt.

Context

• As a 10% owner, Chernett Jorey is a significant shareholder; such purchases indicate the holder increased their stake but do not necessarily reflect management-level trading or day-to-day liquidity needs.
• The filing is a straightforward purchase (not an option exercise, award, or gift). No 10b5-1, tax-withholding, or other special provisions were noted in the provided information.

If you want, I can fetch the full Form 4 text to confirm post-transaction ownership or provide the exact breakdown of trades if/when the filer supplies it.